Works (13)

Updated: July 31st, 2024 05:01

2024 journal article

IL-1β + TGF-β2 dual-licensed mesenchymal stem cells have reduced major histocompatibility class I expression and positively modulate tenocyte migration, metabolism, and gene expression

JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 262.

By: D. Koch n, A. Froneberger n, A. Berglund n, S. Connard n, A. Souther n & L. V. Schnabel n

author keywords: mesenchymal stem cell; tendon; MHC class I; IL-1 beta; TGF-beta 2
Source: Web Of Science
Added: July 22, 2024

2023 journal article

A myristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor peptide attenuates neutrophil outside-in & beta;(2)-integrin activation and signaling

A myristoylated alanine-rich C-kinase substrate (MARCKS) inhibitor peptide attenuates neutrophil outside-in & beta;(2)-integrin activation and signaling. CELL ADHESION & MIGRATION, 17(1), 1–16.

By: H. Conley n, R. Till n, A. Berglund n, S. Jones n & M. Sheats n

author keywords: Beta2-integrin; ICAM-1; MARCKS; neutrophils; outside-in; >
MeSH headings : Alanine; CD18 Antigens / metabolism; Neutrophils; Peptides / pharmacology; Signal Transduction; Myristoylated Alanine-Rich C Kinase Substrate / antagonists & inhibitors
TL;DR: MANS treatment significantly attenuated ICAM-1/Mn2+-stimulated static adhesion, cell spreading andβ2-integrin clustering, suggesting a role for MARCKS function in outside-in β2-Integrin activation. (via Semantic Scholar)
Sources: Web Of Science, ORCID, NC State University Libraries
Added: July 13, 2023

2023 journal article

Effect of gentamicin on <scp>CD3</scp>+ T‐lymphocyte proliferation for treatment of equine recurrent uveitis: An in vitro study

Veterinary Ophthalmology, 26(4), 347–354.

By: H. Smith, A. Berglund n, J. Robertson n, L. Schnabel n, R. McMullen*, B. Gilger n, A. Oh n

author keywords: autoimmune disease; equine recurrent uveitis; gentamicin; horse; immunology; intravitreal injection
TL;DR: Gentamicin had no effect on equine peripheral blood CD3+ T-lymphocyte cell viability and proliferation in concentrations ranging from "safe" to "retinotoxic" in relation to intravitreal injection volumes. (via Semantic Scholar)
Sources: Web Of Science, ORCID, NC State University Libraries, Crossref
Added: April 29, 2023

2022 journal article

Interleukin-1 beta in tendon injury enhances reparative gene and protein expression in mesenchymal stem cells

FRONTIERS IN VETERINARY SCIENCE, 9.

By: D. Koch n, A. Berglund n, K. Messenger n, J. Gilbertie n, I. Ellis n & L. Schnabel n

author keywords: tendon; cytokine; ultrafiltration probe; mesenchymal stem cell; licensing
TL;DR: The defined temporal cytokine microenvironment in a surgically induced model of equine tendon injury and changes in MSC gene and protein expression following in vitro inflammatory licensing with cytokines of similar concentration as identified in vivo support the need to further study the benefit of MSCs administered within the inflamed tendon microenvironment or exogenously licensed with IL-1β in vitro prior to treatment. (via Semantic Scholar)
Source: Web Of Science
Added: December 12, 2022

2022 journal article

TGF-beta 2 enhances expression of equine bone marrow-derived mesenchymal stem cell paracrine factors with known associations to tendon healing

STEM CELL RESEARCH & THERAPY, 13(1).

By: D. Koch n, L. Schnabel n, I. Ellis n, R. Bates n & A. Berglund n

author keywords: Mesenchymal stem cell; Tenocyte; TGF-beta 2; Equine; Tendon; RNA-sequencing; Paracrine factors; Extracellular matrix
MeSH headings : Animals; Bone Marrow / metabolism; Collagen Type I / metabolism; Cytokines / metabolism; Horses; Mesenchymal Stem Cells / metabolism; Paracrine Communication; RNA / metabolism; Tenascin / genetics; Tenascin / metabolism; Tendons / metabolism; Transforming Growth Factor beta2 / genetics; Transforming Growth Factors / metabolism
TL;DR: Treating equine BM-MSCs with TGF-β2 significantly increases production of paracrine factors and extracellular matrix molecules important for tendon healing and promotes the migration of tenocytes in vitro. (via Semantic Scholar)
Source: Web Of Science
Added: September 26, 2022

2021 journal article

Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells

HUMAN GENE THERAPY, 32(17-18), 907–918.

By: A. Cameron*, K. Even*, R. Linardi*, A. Berglund n, L. Schnabel n, J. Engiles*, K. Ortved*

author keywords: osteoarthritis; PTOA; immunomodulation; mesenchymal stem cell; IL-10; AAV
MeSH headings : Animals; Bone Marrow; Cells, Cultured; Dependovirus / genetics; Horses; Interleukin-10 / genetics; Mesenchymal Stem Cells
TL;DR: It is hypothesized that BM-MSCs overexpressing IL-10 would have superior immunomodulatory effects leading to increased suppression of T-cell proliferation and decreased production of pro-inflammatory cytokines providing protection of the extra-cellular matrix (ECM) in a stimulated, co-culture OA model. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: May 24, 2021

2021 article

Effects of continuous passage on the immunomodulator properties of equine bone marrow-derived mesenchymal stem cells in vitro (vol 234, 110203, 2021)

Connard, S. S., Linardi, R. L., Even, K. M., Berglund, A. K., Schnabel, L. V., & Ortved, K. F. (2021, December). VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, Vol. 242.

Source: Web Of Science
Added: March 7, 2022

2021 journal article

Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 234.

author keywords: Horse; Mesenchymal stem cells; Continuous passage; Immunomodulation
MeSH headings : Animals; Bone Marrow Cells / drug effects; Bone Marrow Cells / immunology; Bone Marrow Cells / physiology; Cell Differentiation / drug effects; Cell Differentiation / immunology; Cell Proliferation / drug effects; Cells, Cultured; Cytokines / analysis; Cytokines / biosynthesis; Cytokines / immunology; Female; Horses; Immunomodulation; In Vitro Techniques; Interferon-gamma / pharmacology; Lymphocyte Activation / drug effects; Lymphocyte Activation / immunology; Male; Mesenchymal Stem Cells / immunology; Mesenchymal Stem Cells / physiology
TL;DR: It is demonstrated that culture expansion affects some of the immunomodulatory properties of BM-MSCs in vitro, which may suggest that MSCs isolated from a single collection of bone marrow may be culture expanded, but only those from lower passage numbers would be ideal for clinical application. (via Semantic Scholar)
UN Sustainable Development Goal Categories
Source: Web Of Science
Added: October 12, 2021

2021 journal article

TGF-beta 2 Reduces the Cell-Mediated Immunogenicity of Equine MHC-Mismatched Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Immunomodulatory Properties

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 9.

By: A. Berglund n, J. Long n, J. Robertson n & L. Schnabel n

author keywords: mesenchymal stem cell; TGF-&#946; 2; cytotoxicity; immunogenicity; major histocompatibility complex; allogeneic
TL;DR: It is indicated that treating MSCs with TGF-β2 is a promising strategy to reduce the cell-mediated immunogenicity of MHC-mismatched M SCs and facilitate allogeneic MSC therapy. (via Semantic Scholar)
Sources: Web Of Science, NC State University Libraries
Added: March 8, 2021

2020 journal article

Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting

STEM CELLS TRANSLATIONAL MEDICINE, 10(5), 694–710.

By: A. Rowland*, D. Miller*, A. Berglund n, L. Schnabel n, G. Levine*, D. Antczak*, A. Watts*

author keywords: allogeneic; alloimmunization; antibody; autologous; cross&#8208; match; humoral; innate; intra&#8208; articular; major histocompatibility complex (MHC); MSC
MeSH headings : Adaptive Immunity; Allografts; Animals; Chemokine CXCL12; Histocompatibility Testing / veterinary; Horses; Immunity, Innate; Major Histocompatibility Complex; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Synovial Fluid / immunology; Transplantation, Autologous
TL;DR: Until immune recognition of MSCs can be avoided, repeated clinical use of M SCs should be limited to autologous or cross‐matched allogeneic MSC s, and presensitization against donor MHC should be assessed. (via Semantic Scholar)
Source: Web Of Science
Added: January 11, 2021

2018 journal article

Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators

FRONTIERS IN VETERINARY SCIENCE, 5.

By: J. Gilbertie n, J. Long n, A. Schubert n, A. Berglund n, T. Schaer* & L. Schnabel n

author keywords: platelet-rich plasma lysate; osteoarthritis; IL-1 beta; LPS; HA; collagen type II; aggrecan; MMP-13
TL;DR: The results of this study support continued investigation into the use of pooled PRP-L for the treatment of osteoarthritis and warrant further in-vitro studies to discern the mechanisms of action of PRp-L. (via Semantic Scholar)
Source: Web Of Science
Added: December 17, 2018

2017 journal article

Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro

Stem Cell Research & Therapy, 8(1).

By: A. Sherman n, B. Gilger n, A. Berglund n & L. Schnabel n

author keywords: Mesenchymal stem cells; Equine; Corneal wound healing; Corneal stromal cells/fibroblasts; Scratch assay; TGF-beta 1
MeSH headings : Animals; Biomarkers / metabolism; Bone Marrow Cells / cytology; Corneal Injuries / pathology; Corneal Injuries / therapy; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor / metabolism; Female; Flow Cytometry; Horses; Male; Mesenchymal Stem Cells / cytology; Mesenchymal Stem Cells / metabolism; Transforming Growth Factor beta1 / metabolism; Wound Healing
TL;DR: The significant decrease in scratch area in equine corneal fibroblast cultures treated with autologous BM-MSCs compared to MSC-Sp or control treatments suggests that BM- MSCs may substantially improve corNEal wound healing in horses. (via Semantic Scholar)
Sources: Web Of Science, Crossref, NC State University Libraries
Added: August 6, 2018

2016 journal article

Allogeneic major histocompatibility complex-mismatched equine bone marrow-derived mesenchymal stem cells are targeted for death by cytotoxic anti-major histocompatibility complex antibodies

EQUINE VETERINARY JOURNAL, 49(4), 539–544.

By: A. Berglund n & L. Schnabel n

author keywords: horse; mesenchymal stem cell; allogeneic; major histocompatibility complex-mismatched; antibody response; complement-dependent cytotoxicity
MeSH headings : Animals; Antibodies / immunology; Antibody Formation / immunology; Bone Marrow; Bone Marrow Cells / cytology; Bone Marrow Cells / immunology; Horses; Major Histocompatibility Complex / immunology; Mesenchymal Stem Cells / cytology; Mesenchymal Stem Cells / immunology
TL;DR: The cytotoxic antibody response induced in recipient horses following injection with donor MHC‐mismatched MSCs is capable of killing donor MSCS in vitro. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.